On September 4, 2025, Nukkleus Inc. entered a $10 million private placement agreement to sell 200 units, each priced at $50,000, consisting of convertible preferred stock and warrants. This arrangement allows for the purchase of shares at an initial conversion price of $4.89 per share, with a closing date expected around September 9, 2025.